drugset / Trial / NCT00535639

Tolerability of ALK Tree Tablet

NCT00535639 ↗

Phase 1 Completed ALK-Abelló A/S
RandomizedParallel-groupDouble-blind

Summary

This trial is performed to assess the tolerability of the ALK Tree Tablet in patients with birch pollen induced allergy

Timeline

Start
2007-10
Primary completion
2007-12
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Betula Verrucosa allergen extract Unknown — —

Indications